Article
Forecasting oncogene amplification and tumour suppressor deletion
2025-06-09
Abstract excerpt
Oncogene amplification and tumour suppressor deletion can drive tumour initiation, progression and treatment resistance. Detection at diagnosis often signals poor prognosis, but it can also enable opportunities for treatment with highly effective targeted therapies. Predicting the likelihood that a patient will acquire these driver alterations in the future using a genomic test represents an opportunity to realise...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ce3001a5-6175-5867-9415-998228b5c536
- DOI
- 10.1101/2025.06.06.658212
